Loading...
XHKG0574
Market cap8mUSD
Dec 20, Last price  
0.04HKD
1D
-4.35%
1Q
15.79%
Jan 2017
-91.37%
IPO
-98.00%
Name

Pa Shun International Holdings Ltd

Chart & Performance

D1W1MN
XHKG:0574 chart
P/E
25.94
P/S
0.47
EPS
0.00
Div Yield, %
0.00%
Shrs. gr., 5y
5.72%
Rev. gr., 5y
-30.89%
Revenues
129m
+80.30%
712,111,000794,349,000847,193,000867,963,000860,574,000869,891,000821,142,000845,448,000474,835,00086,426,00071,784,000129,430,000
Net income
2m
P
9,409,00063,070,00045,944,00088,257,0007,675,00010,177,000-59,409,000-193,399,000-419,189,000-54,383,000-43,379,0002,350,000
CFO
-35m
L+1,405.08%
-42,242,00092,225,00048,664,000-35,758,000-777,000-95,981,00017,867,000-58,454,000-6,509,000-21,895,000-2,321,000-34,933,000
Dividend
Jun 06, 20160.03 HKD/sh
Earnings
Feb 21, 2025

Profile

Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution activities in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Self-Operated Retail Pharmacies, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution segment sells pharmaceutical products to wholesalers, franchise retail pharmacy chain stores, and hospitals and other medical institutions in rural areas. The Self-Operated Retail Pharmacies segment engages in the sale of pharmaceutical and healthcare products, cosmetic products, and daily necessities in self-operated retail pharmacies. The Pharmaceutical Manufacturing segment sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017. The company was incorporated in 2011 and is based in San Po Kong, Hong Kong. Pa Shun International Holdings Limited is a subsidiary of Praise Treasure Limited.
URL
https://www.pashun.com.cn
IPO date
Jun 19, 2015
Employees
95
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
129,430
80.30%
71,784
-16.94%
86,426
-81.80%
Cost of revenue
130,843
77,363
98,813
Unusual Expense (Income)
NOPBT
(1,413)
(5,579)
(12,387)
NOPBT Margin
Operating Taxes
1,058
220
408
Tax Rate
NOPAT
(2,471)
(5,799)
(12,795)
Net income
2,350
-105.42%
(43,379)
-20.23%
(54,383)
-87.03%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
115,051
108,711
99,163
Long-term debt
50,919
374
1,658
Deferred revenue
22,005
22,517
23,029
Other long-term liabilities
(1,741)
Net debt
149,459
107,184
56,064
Cash flow
Cash from operating activities
(34,933)
(2,321)
(21,895)
CAPEX
(68)
(28)
(223)
Cash from investing activities
(65)
2,979
24,967
Cash from financing activities
49,610
(1,022)
(6,065)
FCF
(68,385)
113,270
41,807
Balance
Cash
16,511
1,901
2,272
Long term investments
42,485
Excess cash
10,040
40,436
Stockholders' equity
(841,124)
(808,254)
(764,875)
Invested Capital
913,000
823,962
1,101,912
ROIC
ROCE
EV
Common stock shares outstanding
1,474,993
1,474,993
1,474,993
Price
0.03
 
0.07
15.52%
Market cap
45,725
 
98,825
15.52%
EV
195,184
173,541
EBITDA
1,894
(1,954)
(5,949)
EV/EBITDA
103.05
Interest
12,933
10,541
14,951
Interest/NOPBT